The global biosensors market was valued $1.46 billion in 2017.
With the growing prominence of point of care testing services, aided by rising geriatric population and rapid incorporation of biosensing technologies in non-medical applications, the global biosensors market is anticipated to witness an impressive double-digit growth rate. The global biosensors market is currently dominated by electrochemical biosensors.
The high contribution of electrochemical biosensors to the market is attributed to the massive demand for glucose monitoring systems and prolific employment of electrochemical biosensors in them. However, the optical biosensors are anticipated to witness the highest growth rate in the forecast period 2018-2027.
The biosensors pertaining to point of care applications witnessed the highest industry demand in 2017, owing to the high prevalence of chronic diseases. Besides, the biosensing technologies specific to biodefence applications are expected to witness an impressive CAGR of 14.26% in the forecast period 2018-2027.
The global biosensors market is segmented based on the geographical regions into North America, Europe, Asia Pacific, Latin America, and Rest of the World (RoW). North America is the leading contributor to the global biosensors market and contributed 40% of the global market values in 2017.
However, the Asia Pacific biosensors market is anticipated to grow with a double-digit CAGR in the forecast period 2018-2027. The trans-pacific partnership (TPP), which is functional among few nations across the Asia Pacific region, has boosted the growth of Asia Pacific medical device industry, resulting in high demand for biosensing technologies.
Key Topics Covered:
1 Market Overview 1.1 Introduction 1.2 Biosensors: Important Considerations 1.3 Impact of Biosensors 1.4 Future Insights 1.4.1 Important Considerations 1.4.2 Nano-Biosensors Types 1.4.3 Future Applications of Nano-Biosensors 1.5 Global footprint of Biosensors Market 1.6 Assumptions and Limitations
3 Competitive Landscape 3.1 Key Developments and Strategies 3.2 Product Launch 3.3 Joint Ventures, Partnerships and Collaborations 3.4 Merger & Acquisition 3.5 Business Expansions, Approvals/Certifications and Others 3.6 Industry Attractiveness 3.6.1 Bargaining Power of Suppliers 3.6.2 Bargaining Power of Buyers 3.6.3 Threat of New Entrants 3.6.4 Threat of Substitute Products 3.6.5 Intensity of Competitive Rivalry
4 Global Biosensors Market, by Technology 4.1 Overview 4.2 Electrochemical Biosensor Technology 4.3 Optical Biosensor Technology 4.4 Piezoelectric Biosensor Technology 4.5 Thermal Biosensor Technology 4.6 Other Biosensor Technology
5 Global Biosensors Market, by Application 5.1 Overview 5.2 Point of Care 5.2.1 Glucose Monitoring 5.2.2 Cardiac Marker Analysers 5.2.3 Infectious Diseases 5.2.4 Coagulation 5.2.5 Urinalysis 5.2.6 Clinical Chemistry 5.2.7 Women's Health 5.2.8 Cancer Markers 5.2.9 Others 5.3 Environmental Testing 5.3.1 Toxicity Testing 5.3.2 BOD Testing 5.3.3 Contamination Testing 5.3.4 Others 5.4 Research Laboratories 5.5 Home Diagnostics 5.6 Biodefence 5.7 Process Industries
6 Global Biosensors Market, by Region 6.1 Overview 6.2 Role of Macro Economic Factors in the Growth of Global Biosensors Market 6.3 Cluster Analysis: Global Biosensors Market 6.3.1 Cluster-1: China and India 6.3.2 Cluster-2: U.S., U.K., and Japan 6.3.3 Cluster-3: Germany, France, Italy, Brazil, and Mexico 6.3.4 Cluster-4: Canada, Spain, and Thailand 6.3.5 Cluster-5: Switzerland, Ireland, Netherlands, Belgium, Singapore, and Australia 6.4 Global Insights 6.5 North America 6.6 Europe 6.7 Asia Pacific 6.8 Latin America 6.9 Rest of the World